Abstract
Hydrogen sulfide (H2S) is a well-known toxic gas with the smell of rotten eggs. Recent studies have shown that H2S is generated in vivo in human and animal organisms and that it participates in many pathophysiological processes. H2S is produced endogenously in mammalian tissues from L-cysteine metabolism mainly by 3 enzymes: cystathionine β-synthetase (CBS), cystathionine γ-lyase (CSE) and 3-mercaptosulfurtransferase (MST). H2S may not only function as a neuromodulator in the central nervous system but it also relaxes gastrointestinal smooth muscles. More importantly, present evidence shows that H2S exerts regulatory effects on the pathogenesis of various cardiovascular diseases such as hypertension, pulmonary hypertension, shock and myocardial injury. The genomic basis of cystathioninuria in humans is 2 nonsense and 2 sense mutations in CSE. This review reveals that H2S is a new endogenous gaseous transmitter in the cardiovascular system.
Keywords: cysteine aminotransferase, CBS knock-out mice, 3-mercaptopyruvate, neuromodulator, Myocardial damage, hypertension
Current Vascular Pharmacology
Title: Hydrogen Sulfide as a New Endogenous Gaseous Transmitter in the Cardiovascular System
Volume: 4 Issue: 1
Author(s): Chaoshu Tang, Xiaohui Li and Junbao Du
Affiliation:
Keywords: cysteine aminotransferase, CBS knock-out mice, 3-mercaptopyruvate, neuromodulator, Myocardial damage, hypertension
Abstract: Hydrogen sulfide (H2S) is a well-known toxic gas with the smell of rotten eggs. Recent studies have shown that H2S is generated in vivo in human and animal organisms and that it participates in many pathophysiological processes. H2S is produced endogenously in mammalian tissues from L-cysteine metabolism mainly by 3 enzymes: cystathionine β-synthetase (CBS), cystathionine γ-lyase (CSE) and 3-mercaptosulfurtransferase (MST). H2S may not only function as a neuromodulator in the central nervous system but it also relaxes gastrointestinal smooth muscles. More importantly, present evidence shows that H2S exerts regulatory effects on the pathogenesis of various cardiovascular diseases such as hypertension, pulmonary hypertension, shock and myocardial injury. The genomic basis of cystathioninuria in humans is 2 nonsense and 2 sense mutations in CSE. This review reveals that H2S is a new endogenous gaseous transmitter in the cardiovascular system.
Export Options
About this article
Cite this article as:
Tang Chaoshu, Li Xiaohui and Du Junbao, Hydrogen Sulfide as a New Endogenous Gaseous Transmitter in the Cardiovascular System, Current Vascular Pharmacology 2006; 4 (1) . https://dx.doi.org/10.2174/157016106775203144
DOI https://dx.doi.org/10.2174/157016106775203144 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Can Statins Prevent Progression of Degenerated Aortic Valve Stenosis?
Vascular Disease Prevention (Discontinued) Progress Towards Clinically Useful Aldosterone Synthase Inhibitors
Current Topics in Medicinal Chemistry Sleep Disorders Research From 1945 to 2020: A Bibliometric Analysis
CNS & Neurological Disorders - Drug Targets Flow Volumes of Internal Jugular Veins are Significantly Reduced in Patients with Cerebral Venous Sinus Thrombosis
Current Neurovascular Research New Therapeutic Approaches to Arterial Calcification Via Inhibition of Transglutaminase andβ-Catenin Signalin
Current Pharmaceutical Design On Sports And Genes
Recent Patents on DNA & Gene Sequences Dampening the Progression of Dementia
Current Neurovascular Research Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
Current Vascular Pharmacology The Role of Apelins in the Physiology of the Heart
Protein & Peptide Letters Therapeutic Role of Methanolic Extract of Ocimum basilicum L. Seeds and its Isolated Compound as Potent Antidiabetic and Antihyperlipidemic Agents
The Natural Products Journal Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome
Current Pharmaceutical Design Production and Purification of Functional Lipids Through Enzymatic and Microorganism-Mediated Processes
Current Organic Chemistry Design and Development of Novel Azo Prodrugs using Various Permutations and Combinations of 5- and 4-Aminosalicylic Acids for Inflammatory Bowel Disease: A Colon-Targeted Approach
Inflammation & Allergy - Drug Targets (Discontinued) A Review of the Relationships Between Endogenous Sex Steroids and Incident Ischemic Stroke and Coronary Heart Disease Events
Current Cardiology Reviews Glycoprotein Targeting and Other Applications of Lectins in Biotechnology
Current Protein & Peptide Science Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice
Current Medicinal Chemistry Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer’s Disease: Implications for the Treatment
Current Genomics Depression and Vascular Disease: Conceptual Issues, Relationships and Clinical Implications
Vascular Disease Prevention (Discontinued) Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?
CNS & Neurological Disorders - Drug Targets